Lynx1 Capital Management LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$266.7B
Holdings
18
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (18 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 1,580,841 | $66.5B | 24.92% | |
| 2 | STOKSTOKE THERAPEUTICS INC | 5,187,191 | $57.2B | 21.45% | |
| 3 | GHRSGH RESEARCH PLC | 4,858,994 | $34.0B | 12.75% | |
| 4 | CCCCC4 THERAPEUTICS INC | 6,852,744 | $24.7B | 9.25% | |
| 5 | ALLOALLOGENE THERAPEUTICS INC | 10,874,723 | $23.2B | 8.68% | |
| 6 | TCRXTSCAN THERAPEUTICS INC | 5,357,347 | $16.3B | 6.11% | |
| 7 | CGEMCULLINAN THERAPEUTICS INC | 1,257,795 | $15.3B | 5.74% | |
| 8 | KROSKEROS THERAPEUTICS INC | 544,001 | $8.6B | 3.23% | |
| 9 | PASGPASSAGE BIO INC | 9,256,953 | $5.2B | 1.97% | |
| 10 | ALLKGUSDALLAKOS INC | 3,628,144 | $4.4B | 1.65% | |
| 11 | UPBUPSTREAM BIO INC | 240,042 | $3.9B | 1.48% | |
| 12 | DTILPRECISION BIOSCIENCES INC | 766,051 | $2.9B | 1.09% | |
| 13 | IBIOIBIO INC | 862,279 | $2.1B | 0.79% | |
| 14 | CRBUCARIBOU BIOSCIENCES INC | 680,189 | $1.1B | 0.41% | |
| 15 | VORVOR BIOPHARMA INC | 637,218 | $707.3M | 0.27% | |
| 16 | CNTACENTESSA PHARMACEUTICALS PLC | 17,400 | $291.4M | 0.11% | |
| 17 | NEUPNEUPHORIA THERAPEUTICS INC | 45,806 | $157.1M | 0.06% | |
| 18 | RPTXREPARE THERAPEUTICS INC | 79,176 | $103.7M | 0.04% |